PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis

Renal cancer is characterized by overexpression of growth factors; epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and insulin growth factor (IGF) that will induce the activation of the phosphatidyl-3-kinase-protein-kinase B-mammalian target of rapamycin (PI3K/AKT/mTOR) and RAS/MEK/ERK (RAS/mitogen-activated protein kinase/extracellular signal-regulated kinase). Further, this molecular signaling pathway inhibits the Von Hippel-Lindau (VHL) gene leading to the activation of hypoxia-inducible factors (HIFs) involved in renal cancer-reprogramming metabolism. Therefore, regarding glucose metabolism, this malignancy has increased glycolysis, glycogenolysis, pentose phosphate pathway (PPP), and increased tricarboxylic acid cycle (TCA), leading to lactate, pyruvate, NADPH, ribose-5-phosphate, malate, succinate, citrate, and acetyl-CoA accumulation. Additionally, the RAS/MEK/ERK signaling pathway promotes glycolysis and TCA. The compounds that resulted from altering glucose metabolism are involved in glutathione (GSH) regeneration, lipids, nucleotides, and amino acids (AA) biosynthesis. Fatty acids (FA) are used to produce energy by β-oxidation. Lipid metabolism alterations also include synthesis of FA, TAG (triacylglycerols), cholesterol, ceramides, sphingolipids, and phosphatidylcoline/phosphatidylethanolamine. Amino acids such as glutamine can suffer several modifications forming glutamate, α-ketoglutarate, and aspartate. The intermediates together with increased Tyr (tyrosine) and decreased Arg (arginine) and Trp (tryptophan) will be used by renal cancer cells for the synthesis of new AA, nucleotides, FA, citrate, oxaloacetate (OAA), and pyrimidine bases. All these compounds that result from the altered pathway lead to cancer cell survival, aggressiveness, and metastasis. These characteristics of malignant tumors are also promoted by cyclin D1 deregulation produced by mTORC1 by activating S6K and 4E-BP1. + represents activation; − means inhibited
PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis

Publication

PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis (2023) Silviu Constantin Badoiu, et al. Int J Mol Sci. 2023 May;24(9). Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates VEGF, VEGF ncbigene_synonym VEGFA 7422
Homo sapiens Primates VEGF, VEGF famplex_relations VEGFB 7423
Homo sapiens Primates VEGF, VEGF famplex_relations VEGFC 7424
Homo sapiens Primates VEGF, VEGF famplex_relations VEGFD 2277
Homo sapiens Primates VEGF, VEGF famplex_relations PGF 5228
Homo sapiens Primates HGF HGF ncbigene_symbol HGF 3082
Homo sapiens Primates HGF HGF ncbigene_synonym IL6 3569
Homo sapiens Primates HGF HGF ncbigene_synonym SOS1 6654
Homo sapiens Primates EGF, EGF ncbigene_symbol EGF 1950
Homo sapiens Primates EGFR. EGFR ncbigene_symbol EGFR 1956
Homo sapiens Primates IGFR IGFR ncbigene_synonym IGF1R 3480
Homo sapiens Primates VEGFR. VEGFR ncbigene_synonym KDR 3791
Homo sapiens Primates VEGFR. VEGFR famplex_relations FLT1 2321
Homo sapiens Primates VEGFR. VEGFR famplex_relations FLT4 2324
Homo sapiens Primates RAS RAS famplex_relations KRAS 3845
Homo sapiens Primates RAS RAS famplex_relations HRAS 3265
Homo sapiens Primates RAS RAS famplex_relations NRAS 4893
Homo sapiens Primates ERK ERK ncbigene_synonym EPHB2 2048
Homo sapiens Primates ERK ERK ncbigene_synonym MAPK1 5594
Homo sapiens Primates ERK ERK famplex_relations MAPK3 5595
Homo sapiens Primates MEK MEK ncbigene_synonym MAP2K7 5609
Homo sapiens Primates MEK MEK famplex_relations MAP2K1 5604
Homo sapiens Primates MEK MEK famplex_relations MAP2K2 5605
Homo sapiens Primates VHL VHL ncbigene_symbol VHL 7428
Homo sapiens Primates AKT AKT ncbigene_synonym AKT1 207
Homo sapiens Primates AKT AKT famplex_relations AKT2 208
Homo sapiens Primates AKT AKT famplex_relations AKT3 10000
Homo sapiens Primates PI3K/AKT/mTORactivation PI3K ncbigene_synonym PIK3CA 5290
Homo sapiens Primates PI3K/AKT/mTORactivation PI3K ncbigene_synonym PIK3CB 5291
Homo sapiens Primates PI3K/AKT/mTORactivation PI3K ncbigene_synonym PIK3CD 5293
Homo sapiens Primates PI3K/AKT/mTORactivation PI3K ncbigene_synonym PIK3CG 5294
Homo sapiens Primates PI3K/AKT/mTORactivation PI3K famplex_relations PIK3R3 8503
Homo sapiens Primates PI3K/AKT/mTORactivation PI3K famplex_relations PIK3R4 30849
Homo sapiens Primates PI3K/AKT/mTORactivation PI3K famplex_relations PIK3R5 23533
Homo sapiens Primates PI3K/AKT/mTORactivation PI3K famplex_relations PIK3R6 146850
Homo sapiens Primates PI3K/AKT/mTORactivation PI3K famplex_relations PIK3R1 5295
Homo sapiens Primates PI3K/AKT/mTORactivation PI3K famplex_relations PIK3R2 5296
Homo sapiens Primates mTOR MTOR ncbigene_symbol MTOR 2475
Homo sapiens Primates mTORC2 MTORC2 famplex_relations MAPKAP1 79109
Homo sapiens Primates mTORC2 MTORC2 famplex_relations RICTOR 253260
Homo sapiens Primates mTORC2 MTORC2 famplex_relations MLST8 64223
Homo sapiens Primates larg LARG ncbigene_synonym ARHGEF12 23365
Homo sapiens Primates TAG TAG ncbigene_synonym TMED7 51014
Homo sapiens Primates TAG TAG ncbigene_synonym LINC01194 404663
Homo sapiens Primates NADPH NADPH ncbigene_synonym DECR1 1666

Chemical mentions

Word Match MeSH Name ChEBI
SOK SOK 2-chloro-4,5-dimethylphenyl methylcarbamate chebi:82090
Glutamine GLUTAMINE L-glutamine chebi:18050
Glutamate Glutamate (2S)-2-aminopentanedioic acid chebi:16015
Aspartate aspartate chebi:72314
Lactate lactate lactate chebi:24996
Pyruvate pyruvate pyruvate chebi:15361
NADPH NADPH 2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57783
Malate Malate (2S)-2-hydroxybutanedioic acid chebi:30797
Succinate succinate succinate chebi:30031
Citrate citrate chebi:133748
Ceramides ceramides a ceramide chebi:17761
Phosphatidylethanolamine PHOSPHATIDYLETHANOLAMINE (7S)-4-hydroxy-7-(octadecanoyloxy)-10-oxo-3,5,9-trioxa-4-phosphaheptacosan-1-aminium 4-oxide chebi:44887
GSH GSH L-gamma-glutamyl-L-cysteinylglycine chebi:16856
Nucleotides nucleotides chebi:36976
Citrate citrate chebi:133748
OAA OAA chebi:132560

Disease mentions

Word Match MeSH Name DOID
cancer cancer cancer DOID:162